Recent Acquisition and Rebranding Körber Tissue has recently transitioned its operations to become part of Valmet's Tissue Converting business unit, indicating strategic growth and integration in the tissue manufacturing sector, which may open up cross-selling opportunities for related machinery and services.

Market Position and Size With a revenue range of 10 to 25 million dollars and a workforce of up to 200 employees, the company targets mid-sized market segments, presenting potential for scalable automation solutions and machinery upgrades tailored to similar firms.

Industry Focus and Expertise Specialized in industrial machinery manufacturing within the tissue industry, Körber Tissue's expertise positions it as a key player for suppliers and service providers aiming to expand their reach within tissue converting applications.

Growth Opportunities The company's recent integration into Valmet suggests potential for expanded product offerings and technological innovation, providing avenues for sales of advanced machinery, software solutions, and modernization services.

Competitive Landscape Operating alongside similar firms with varying sizes and revenues, Körber Tissue represents a strategic prospect for partners seeking to enter or expand within the tissue converting machinery segment, leveraging existing industry relationships.